NM_012434.5:c.1001C>G
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_012434.5(SLC17A5):c.1001C>G(p.Pro334Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_012434.5 missense
Scores
Clinical Significance
Conservation
Publications
- free sialic acid storage diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Salla diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Genomics England PanelApp, Myriad Women’s Health
- free sialic acid storage disease, infantile formInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
- intermediate severe Salla diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Sialic acid storage disease, severe infantile type Pathogenic:3
- -
- -
This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
Salla disease Pathogenic:1
This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 334 of the SLC17A5 protein (p.Pro334Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with sialic acid storage disorder (PMID: 10581036). ClinVar contains an entry for this variant (Variation ID: 5619). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC17A5 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SLC17A5 function (PMID: 15510212, 15516337, 18399798, 21781115). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Sialic acid storage disease, severe infantile type;C1096903:Salla disease Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at